Related Experiment Video
Updated: Apr 14, 2026

Isolation and Characterization of Neutrophils with Anti-Tumor Properties
Published on: June 19, 2015
Conducting cancer research in a conflict setting: a view from the occupied Palestinian territory
Shaymaa AlWaheidi1, Anas Ismail2, Richard Sullivan3
1Centre for Cancer , Society & Public Health, King's College London, London SE1 9RT, UK.
Abstract:
Cancer is now the third leading cause of death in low-income countries (65% of cancer deaths globally), accounting for over 4 million deaths every year. Despite this, research on cancer control and access to cancer care in low-income countries is limited and that in conflict settings rare. The acute and chronic nature of conflict and the vulnerability of populations caught within it, allow researchers only narrow windows of opportunity to gather and follow-up cancer data prospectively. This is usually accompanied by a lack of infrastructure and trained human resources, absence of reliable and timely data, eroded trust and poorly coordinated healthcare systems. These factors make it difficult for local researchers to conduct research, and even more difficult for international researchers to bring their skills into the setting due to movement restrictions and a lack of awareness of the local context, increasing the possibility of misjudging necessities. The problems of research in conflict go beyond the risk to the personal safety and mental health of research teams in conflict settings. Taken together, these factors could explain why opportunities for systematic data collection in conflict settings are limited despite being essential to reduce the gap in outcomes among patients with cancer living in low-income and conflict settings and those living in high-income countries. Drawing on 2 years of field research in Gaza in the occupied Palestinian territory (oPt), a conflict area in the Middle East, we present our observations from a study on breast cancer.
Related Concept Videos
Cancer
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Treatment Resistent Cancers
Treatment Resistant Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

